Offering available in different locale
Active pharmaceutical ingredient (API) and drug substance development services from preclinical to Phase III, and commercial manufacturing for complex, niche small molecules.
Offering available in different locale
From development to delivery — integrated CDMO solutions tailored for your molecule’s journey.
Offering available in different locale
Advancing API solid form research and development programs.
Offering available in different locale
Offering available in different locale
Offering available in different locale
Offering available in different locale
Offering available in different locale
Offering available in different locale
Offering available in different locale
Offering available in different locale
Offering available in different locale
Offering available in different locale
Offering available in different locale
Advanced science. Agile execution. Global reach.
Eurofins CDMO is recognised for its exceptional performance in the Small Molecule API category within North America.
Eurofins CDMO’s new North American Biologics facility will expand clinical commercial capabilities for monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs) and sterile fill finish.
Drug development and manufacturing for biologics and small molecules, with integrated services from preclinical, clinical to commercial.
With over two decades of expertise, we deliver integrated drug development and manufacturing services, ensuring seamless pathways for your programme from preclinical to commercialisation.
We are proud to serve a diverse range of clients, from early-stage startups to pharmaceutical companies, providing individualised, flexible and high-quality service to all.
Currently manufacturing several API (Active Pharmaceutical Ingredient) products, we combine expertise in small molecules, biologics, and ADCs with specialised services designed to de-risk and accelerate product development.
Underpinned by a strong quality and project management system, our team of experts navigate complex regulatory compliance within quality frameworks with a focus on timeline, budget and communication.